Blank check company merger creates cancer specialist Vincera

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 30, 2020 at 10:43 AM.

  1. #1 cafead, Sep 30, 2020 at 10:43 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,172
    Likes Received:
    3
    via LifeSci Acquisition – a so-called ‘blank check’ company – has announced a $60 million merger with Vincera Pharma that will focus on developing cancer drugs.

    The combined company will be called Vincera and will focus its initial energies on a clinical-stage PTEFb/CDK9 inhibitor and preclinical bioconjugation platform, both licensed from German group Bayer.

    article source
     
    Quote

Reply to Thread